HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Min Mao Selected Research

metadoxine

3/2009[Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Min Mao Research Topics

Disease

5Fibrosis (Cirrhosis)
09/2010 - 11/2003
2Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 05/2021
2Non-alcoholic Fatty Liver Disease
01/2023 - 01/2017
2Liver Diseases (Liver Disease)
01/2023 - 12/2003
2Pulmonary Arterial Hypertension
11/2020 - 08/2014
2Familial Primary Pulmonary Hypertension
08/2014 - 10/2012
2Liver Cirrhosis (Hepatic Cirrhosis)
09/2010 - 11/2003
2Chronic Hepatitis B
12/2005 - 11/2003
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Pulmonary Hypertension
11/2020
1Pulmonary Embolism
11/2017
1Acute Liver Failure (Fulminant Hepatic Failure)
08/2017
1Diabetes Mellitus
01/2017
1Lung Neoplasms (Lung Cancer)
01/2015
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2015
1Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
08/2014
1Congenital Heart Defects (Congenital Heart Defect)
08/2014
1Infections
09/2010
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
03/2009
1Hepatitis
11/2004
1Hepatitis A (Hepatitis, Infectious)
11/2004
1Inflammation (Inflammations)
12/2003
1Drug-Related Side Effects and Adverse Reactions
11/2003

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
09/2010 - 11/2003
4Hyaluronic Acid (Hyaluronan)IBA
12/2005 - 11/2003
3AlbuminsIBA
09/2010 - 11/2003
3Capsules (Microcapsules)IBA
03/2009 - 11/2003
2Alanine Transaminase (SGPT)IBA
01/2023 - 05/2021
2Triglycerides (Triacylglycerol)IBA
01/2023 - 05/2021
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
09/2010 - 12/2005
2oxymatrineIBA
11/2004 - 11/2003
2GlobulinsIBA
12/2003 - 11/2003
1Cardiovascular AgentsIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1GasesIBA
01/2022
1SmokeIBA
01/2022
1Spermine SynthaseIBA
11/2020
1MonocrotalineIBA
11/2020
1SpermineIBA
11/2020
1Becaplermin (PDGF-BB)FDA Link
11/2020
1Acetaminophen (Paracetamol)FDA LinkGeneric
08/2017
1Streptozocin (Streptozotocin)FDA Link
01/2017
1Fatty Acids (Saturated Fatty Acids)IBA
01/2017
1Methionine (L-Methionine)FDA Link
01/2017
1Insulin (Novolin)FDA Link
01/2017
1Choline (Choline Chloride)IBA
01/2017
1LipidsIBA
01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2015
1Interleukin-6 (Interleukin 6)IBA
01/2015
1Appetite Depressants (Anorectics)IBA
08/2014
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
08/2014
1Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
08/2014
1hydralazine 4-anisaldehyde hydrazoneIBA
10/2012
1aluminum borideIBA
09/2010
1metadoxineIBA
03/2009
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
12/2005
1Hepatitis B e AntigensIBA
12/2005
1peptide PIBA
11/2004
1Prostaglandins AIBA
12/2003
1ProcollagenIBA
12/2003
1ApoproteinsIBA
12/2003
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2003
1Transforming Growth Factor beta (TGF-beta)IBA
11/2003
1Tissue Inhibitor of Metalloproteinase-1IBA
11/2003

Therapy/Procedure

3Therapeutics
11/2017 - 11/2003
1Catheters
11/2017